ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
-0.3%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$245M
AUM Growth
+$245M
(-11%)
Cap. Flow
-$16.3M
Cap. Flow
% of AUM
-6.66%
Top 10 Holdings %
Top 10 Hldgs %
69.54%
Holding
73
New
6
Increased
11
Reduced
12
Closed
12
Top Buys
| 1 |
Ascendis Pharma
ASND
|
$10.4M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$9.69M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$7.78M |
| 4 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
$3.92M |
| 5 |
Evolent Health
EVH
|
$3.31M |
Top Sells
| 1 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$11.3M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$9M |
| 3 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$5.98M |
| 4 |
Marvell Technology
MRVL
|
$5.34M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$4.26M |
Sector Composition
| 1 | Healthcare | 88.05% |
| 2 | Communication Services | 0% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ascendis Pharma
ASND
$11.8B
| $25.7M | 7.18% | 924,483 +374,483 | +68% | +$10.4M |
|
2
Veracyte
VCYT
$2.39B
| $25.7M | 7.18% | 3,080,145 -3,414 | -0.1% | -$28.4K |
|
3
Iovance Biotherapeutics
IOVA
$807M
| $25.1M | 7.02% | 3,415,044 | – | – |
|
4
Assembly Biosciences
ASMB
$190M
| $21.3M | 5.95% | 1,030,072 -69,928 | -6% | -$1.44M |
|
5
IRIDEX
IRIX
$22.8M
| $17.2M | 4.81% | 1,737,540 +45,675 | +3% | +$452K |
|
6
PDS Biotechnology
PDSB
$57.8M
| $15.4M | 4.32% | 1,504,612 +153,096 | +11% | +$1.57M |
|
|
IMMU
7
DELISTED
Immunomedics Inc
IMMU
| $14.1M | 3.95% | 1,600,000 +1,097,000 | +218% | +$9.69M |
|
|
NBRV
8
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $9.91M | 2.77% | 945,737 +268,027 | +40% | +$2.81M |
|
|
CEMI
9
DELISTED
Chembio diagnostics, Inc.
CEMI
| $8.22M | 2.3% | 1,358,351 +156,207 | +13% | +$945K |
|
|
KITE
10
DELISTED
Kite Pharma, Inc.
KITE
| $7.78M | 2.18% | +75,000 | New | +$7.78M |
|
|
11
Evolent Health
EVH
$1.12B
| $7.11M | 1.99% | 280,600 +130,600 | +87% | +$3.31M |
|
|
RARX
12
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $7M | 1.96% | 373,507 +125,551 | +51% | +$2.35M |
|
|
13
Acadia Pharmaceuticals
ACAD
$4.38B
| $6.97M | 1.95% | 250,000 -322,756 | -56% | -$9M |
|
|
CASM
14
DELISTED
CAS Medical Systems, Inc.
CASM
| $5.52M | 1.55% | 4,760,151 +337,651 | +8% | +$392K |
|
|
VIVE
15
DELISTED
VIVEVE MED INC
VIVE
| $5.1M | 1.43% | 710,000 -430,000 | -38% | -$3.09M |
|
|
VRAY
16
DELISTED
ViewRay, Inc.
VRAY
| $4.44M | 1.24% | 686,387 +85,314 | +14% | +$552K |
|
|
ZGNX
17
DELISTED
Zogenix, Inc.
ZGNX
| $4.38M | 1.22% | 301,700 -135,413 | -31% | -$1.96M |
|
|
QTNT
18
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $4.06M | 1.14% | 551,196 +532,296 | +2,816% | +$3.92M |
|
19
AnaptysBio
ANAB
$569M
| $3.97M | 1.11% | 165,690 | – | – |
|
|
DBVT
20
DBV Technologies
DBVT
$264M
| $3.85M | 1.08% | 107,765 -41,925 | -28% | -$1.5M |
|
|
TSRO
21
DELISTED
TESARO, Inc.
TSRO
| $3.32M | 0.93% | 23,700 -11,300 | -32% | -$1.58M |
|
22
argenx
ARGX
$43.6B
| $3.24M | 0.91% | +152,837 | New | +$3.24M |
|
23
Aclaris Therapeutics
ACRS
$209M
| $2.44M | 0.68% | 90,000 -110,000 | -55% | -$2.98M |
|
24
Indaptus Therapeutics
INDP
$7.19M
| $2.28M | 0.64% | +400,000 | New | +$2.28M |
|
|
NDRM
25
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $2.18M | 0.61% | 72,866 -377,134 | -84% | -$11.3M |
|